BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN, L2
Completes Acquisition of Avadel Pharmaceuticals plc, Accelerating Entry Into Sleep Medicine Market
Other Events
Shareholders Approve the Proposed Acquisition
Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
Announces Increased Offer to Acquire
Board of Directors Declares Proposal a 'Company Superior Proposal'
Receives Unsolicited Proposal
Q3
Q2
Q1
FY 2024
FY 2023 amended
Notice of Suspension of Duty to File Reports
Effectiveness Notice
S-3ASR
Registration Statement for Securities to be Offered to Employees
Additional Proxy Materials
Definitive Merger Proxy Statement
PRER14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
S-8 POS
Post-Effective Amendment to Registration Statement